Amy S. Broidrick, EVP, Chief Strategy Officer at Qualigen Therapeutics, Inc. (QLGN), bought 4,500 shares at $2.03 ($9K) on 2021-04-26, disclosed to the SEC on 2021-04-26.
Open-market purchase of $9k QLGN by EVP, Chief Strategy Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.